However, basal ERK1/2 activity has been shown to be essential for maintaining endothelial integrity in vivo, and ERK1/2 loss leads to rapid development of hypertension and death within 5 weeks due to widespread endothelial-to-mesenchymal transition and degradation of endothelial cells in various organs [267]. The gene discussed is MAPK3; the disease is hypertensive disorder.